Remifentanil-induced inflammation in microglial cells: Activation of the PAK4-mediated NF-κB/NLRP3 pathway and onset of hyperalgesia.

MLA

Cui, Chang, et al. “Remifentanil-Induced Inflammation in Microglial Cells: Activation of the PAK4-Mediated NF-ΚB/NLRP3 Pathway and Onset of Hyperalgesia.” Brain, Behavior & Immunity, vol. 123, Jan. 2025, pp. 334–52. EBSCOhost, https://doi.org/10.1016/j.bbi.2024.09.018.

APA

Cui, C., Wu, X., Dong, S., Chen, B., & Zhang, T. (2025). Remifentanil-induced inflammation in microglial cells: Activation of the PAK4-mediated NF-κB/NLRP3 pathway and onset of hyperalgesia. Brain, Behavior & Immunity, 123, 334–352. https://doi.org/10.1016/j.bbi.2024.09.018

Chicago

Cui, Chang, Xiaochu Wu, Shuhua Dong, Benzhen Chen, and Tianyao Zhang. 2025. “Remifentanil-Induced Inflammation in Microglial Cells: Activation of the PAK4-Mediated NF-ΚB/NLRP3 Pathway and Onset of Hyperalgesia.” Brain, Behavior & Immunity 123 (January): 334–52. doi:10.1016/j.bbi.2024.09.018.